MedX Health Corp (MDXHF)
- Previous Close
0.0500 - Open
0.0500 - Bid 0.0008 x --
- Ask 0.0500 x --
- Day's Range
0.0500 - 0.0500 - 52 Week Range
0.0300 - 0.0600 - Volume
39,000 - Avg. Volume
1,406 - Market Cap (intraday)
13.509M - Beta (5Y Monthly) 1.26
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Nov 26, 2024 - Dec 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It also operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment. MedX Health Corp was incorporated in 1999 and is headquartered in Mississauga, Canada.
www.medxhealth.comRecent News: MDXHF
View MorePerformance Overview: MDXHF
Trailing total returns as of 10/23/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MDXHF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MDXHF
View MoreValuation Measures
Market Cap
11.73M
Enterprise Value
16.42M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
41.86
Price/Book (mrq)
--
Enterprise Value/Revenue
58.38
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-220.68%
Return on Equity (ttm)
--
Revenue (ttm)
388.64k
Net Income Avi to Common (ttm)
-3.82M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
161.49k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.44M
Company Insights: MDXHF
MDXHF does not have Company Insights